Bioorganic & Medicinal Chemistry Letters 2003-05-19

2,4-disubstituted pyrimidines: a novel class of KDR kinase inhibitors.

Peter J Manley, Adrienne E Balitza, Mark T Bilodeau, Kathleen E Coll, George D Hartman, Rosemary C McFall, Keith W Rickert, Leonard D Rodman, Kenneth A Thomas

Index: Bioorg. Med. Chem. Lett. 13(10) , 1673-7, (2003)

Full Text: HTML

Abstract

2,4-Disubstituted pyrimidines were synthesized as a novel class of KDR kinase inhibitors. Evaluation of the SAR of the screening lead compound 1 (KDR IC(50)=105 nM, Cell IC(50)=8% inhibition at 500 nM) led to the potent 3,5-dimethylaniline derivative 2d (KDR IC(50)=6 nM, cell IC(50)=19 nM).

Related Compounds

  • 2-methylthio-4-chl...

Related Articles:

Concise total syntheses of variolin B and deoxyvariolin B.

2005-08-05

[J. Org. Chem. 70(16) , 6204-12, (2005)]

Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors.

2007-03-22

[J. Med. Chem. 50 , 1146, (2007)]

Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.

2007-07-26

[J. Med. Chem. 50 , 3497, (2007)]

Pyrimidines. XIII. 2-and 6-substituted 4-pyrimidinecarboxylic acids. Daves GD, et al.

[J. Heterocycl. Chem. 1(3) , 130-133, (1964)]

More Articles...